Sleep and Ventricular Arrhythmias Study
Completed · Phase 2
Conditions studied: Cardiac Arrhythmia, Implantable Defibrillator User, Insomnia
In brief
This is a single-center, randomized controlled trial study design. Enrolled participants have a cardiovascular condition for which they are undergoing implantable cardioverter defibrillator (ICD) therapy and comorbid insomnia. Participants were randomized to a behavioral intervention for insomnia in ICD patients or a waitlist control. The treatment intervention period lasted 4 weeks with a telephone booster session administered at 3 month follow-up. The objective of the study is to examine the impact of a brief therapy combining established behavioral approaches to treating insomnia with novel components to target negative cognitions and anxieties associated with cardiac disease and ICD implantation. Primary patient outcomes include sleep, psychological functioning, daytime functioning, cardiac functioning, cognitive performance, and ICD adjustment.
Key facts
- Study ID
- NCT02232204
- Run by
- University of Florida
- People needed
- 3
- Starts
- 2009-10-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2014-09-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Current ICD implantation (single or dual lead ICD, ICD and pacemaker)
- Diagnosis of insomnia
- No sleep medications for at least 1 month, or stable on medications for at least 6 months
- Willing to be randomly assigned to treatment
- Able to read and understand English
You may not qualify if…
- Sleep disorder other than insomnia
- Significant medical condition other than cardiac disease
- Severe untreated psychopathology
- Neurological disorder
- Cognitive impairment
Where it is running
- University of Florida Aging — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.